Evidence map›Paper›PMID 35303190›Full record

Trial reportAIDS and behavior2022

Development of a Telephone-Delivered Acceptance and Commitment Therapy Intervention for People Living with HIV who are Hazardous Drinkers.

Sarah E Woolf-King, Madison Firkey, Jacklyn D Foley, Jonathan Bricker, Judith A Hahn, Elizabeth Asiago-Reddy, John Wikier, Dezarie Moskal, Alan Z Sheinfil, Jeremy Ramos and 1 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Sarah E Woolf-KingDepartment of Psychology, Syracuse University, Syracuse, NY, US. sewoolf@syr.edu.ORCID http://orcid.org/0000-0002-5612-1114
Madison FirkeyDepartment of Psychology, Syracuse University, Syracuse, NY, US.
Jacklyn D FoleyBehavioral Medicine Program, Massachusetts General Hospital, Boston, MA, US.
Jonathan BrickerFred Hutchinson Cancer Research Center, Seattle, WA, US.
Judith A HahnSan Francisco Department of Medicine, University of California, San Francisco, CA, US.
Elizabeth Asiago-ReddyDepartment of Medicine, SUNY Upstate Medical University, Syracuse, NY, US.
John WikierDepartment of Medicine, SUNY Upstate Medical University, Syracuse, NY, US.
Dezarie MoskalVA Center for Integrated Healthcare, VA WNY Healthcare System, Buffalo, NY, US.
Alan Z SheinfilDepartment of Psychology, Syracuse University, Syracuse, NY, US.
Jeremy RamosDepartment of Psychology, Syracuse University, Syracuse, NY, US.
Stephen A MaistoDepartment of Psychology, Syracuse University, Syracuse, NY, US.
Syracuse University · USSUNY Upstate Medical University · USMassachusetts General Hospital · USUniversity of California, San Francisco · USUniversity of Washington · USVA Western New York Healthcare System · US

Funding

Training in Research Program on Alcohol Use by Persons with our at Risk for HIVK24AA022586 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2013 to 2023
$1.8M
Phase I Study of Mistletoe Extract and GemcitabineZ01AT000005 · NCCIH · NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH · PI MANSKY, PATRICK J · 2002 to 2008
$1.1M
High Dose Alpha Tocopherol and Carotid AtherosclerosisR01AT000005 · NCCIH · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI JIALAL, ISHWARLAL · 1999 to 2004
$917k
Brief Acceptance and Commitment Therapy for HIV-Infected At-Risk Drinkers Administrative SupplementR34AA026246 · NIAAA · SYRACUSE UNIVERSITY · PI MAISTO, STEPHEN A, WOOLF-KING, SARAH E · 2018 to 2021
$897k
Intramural NIH HHS Z01 AT000005National Center for Complementary and Alternative Medicine T32AT00005NCCIH NIH HHS R01 AT000005NIAAA NIH HHS K24 AA022586NIAAA NIH HHS K24AA022586NIAAA NIH HHS R34 AA026246NIAAA NIH HHS R34AA026246
6 · The paper itself

Abstract

Alcohol use among people living with HIV (PWH) has been increasingly recognized as an important component of HIV care. Transdiagnostic treatments, such as Acceptance and Commitment Therapy (ACT), that target core processes common to multiple mental health and substance-related problems, may be ideal in HIV treatment settings where psychological and behavioral health comorbidities are high. In advance of a randomized clinical trial (RCT), the overall objective of this study was to systematically adapt an ACT-based intervention originally developed for smoking cessation, into an ACT intervention for PWH who drink at hazardous levels. Consistent with the ADAPT-ITT model, the adaptation progressed systematically in several phases, which included structured team meetings, three focus group discussions with PWH (N = 13), and in-depth interviews with HIV providers (N = 10), and development of standardized operating procedures for interventionist training, supervision, and eventual RCT implementation. The procedures described here offer a template for transparent reporting on early phase behavioral RCTs.

Indexed as

Acceptance and Commitment TherapyHIV InfectionsSmoking CessationHumansMental HealthTelephoneACTAlcoholHIVTreatment

Identifiers

PMID35303190
PMCPMC8931450
OpenAlexW4220883152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.